当前位置: 首页 > 期刊 > 《中国当代医药》 > 2011年第19期
编号:12109238
IgA肾病的治疗进展
http://www.100md.com 2011年7月5日 《中国当代医药》 2011年第19期
     [摘要] IgA肾病是一免疫病理诊断,它是世界上最常见的原发性肾小球肾炎,目前尚无特异性治疗。治疗主要是缓解症状和延缓病情进展,措施包括一般治疗如饮食限制、血压控制等,免疫抑制治疗,联合治疗和扁桃体切除等。现仅就当前IgA肾病的治疗作一综述。

    [关键词] IgA肾病;治疗;免疫抑制;血压控制

    [中图分类号] R692 [文献标识码]A[文章编号]1674-4721(2011)07(a)-014-03

    Progress in therapy of IgA nephropathy

    XING Feizhong1, WANG Gang2

    1.Leizhou People′s Hospital, Guangdong Province, Leizhou 524200, China; 2.Institute of Nephrology, the Affiliated Hospital of Guangdong Medical College, Guangdong Province, Zhanjiang 524003, China

    [Abstract] IgA nephropathy (IgAN) is an immunopathological diagnosis. It is the most common primary glomerulonephritis worldwide, for which there is no specific therapy now. Present treatments are mainly to reduce symptoms, relieve patients′ pains and delay the progress of the disease. Curative methods include general treatment, such as diet restiction, blood pressure control, immunosuppressive treatment, combination treatment, tonsillectomy and so on. Here we reviwed the therapy of IgAN and its progress in recent years as follows. ......
1 2 3下一页

您现在查看是摘要页,全文长 4942 字符